Cancer treatment, in particular radiotherapy and chemotherapy, is often hindered by an
inherent resistance of cancer cells. Cancer stem cells in particular have previously been shown …

Background Initial results of the ChemoRadiotherapy for Oesophageal cancer followed by
Surgery Study (CROSS) comparing neoadjuvant chemoradiotherapy plus surgery versus …

PURPOSE Preoperative chemoradiotherapy according to the chemoradiotherapy for esophageal
cancer followed by surgery study (CROSS) has become a standard of care for patients …

Standard staging of esophageal and gastroesophageal junction (GEJ) tumors substantially
lacks accuracy. The aim of this study was to investigate whether the addition of PET with 18 F-…

Purpose To compare pre-agreed health-related quality of life (HRQOL) domains in patients
with esophageal or junctional cancer who received neoadjuvant chemoradiotherapy (nCRT) …

Adequate prediction of tumor response to neoadjuvant chemoradiotherapy (nCRT) in
esophageal cancer (EC) patients is important in a more personalized treatment. The current best …

Background and purpose In this study, we investigated whether cancer stem cell marker
expressing cells can be identified that predict for the response of esophageal cancer (EC) to …

Distant metastases or local invasion are frequently found during the explorative phase of
surgery for esophageal cancer. This study was performed to determine the rate of patients with …

Because of improvements in diagnostic technology, the incidental detection of synchronous
primary tumors during the preoperative work-up of patients with esophageal cancer has …

Background Neoadjuvant chemoradiotherapy (CRT) improves locoregional control and
overall survival in esophageal cancer patients. Although adverse events are relatively low …